Thousands of people from dozens of countries came together in Barcelona this year for Patient Community Day 2025 at the ...

Fatigue is experienced by approximately 80% of people with multiple sclerosis, significantly impacting their quality of life and functional ability. To discuss the latest advancements in fatigue ...

As an FDA advisory panel meets Wednesday to vote on whether to recommend approval of Sanofi’s MS drug Lemtrada, patient opinion leaders have already voiced their view. A small majority told ...

A comprehensive look into MS treatment objectives is provided. Ryan Haumschild, PharmD, MS, MBA: In your thoughts, what are the outcomes that patients with multiple sclerosis [MS] are most interested ...

“This study found that having bladder problems was significantly associated with lower well-being in [people with] MS, particularly when considering OAB. Bowel problems, self-management of bladder ...

In a longitudinal cohort study, patients with multiple sclerosis underwent cognitive evaluation and magnetic resonance imaging scans at baseline and after 3 years. Memory decline was observed in ...

Through a multitude of assessment tools, findings suggest that lower amounts of physical activity directly correlate with higher rates of fatigue in patients with relapsing-remitting multiple ...

There is currently no cure for Multiple Sclerosis (MS). Patients rarely do well with no therapy at all, and it is generally recommended that patients with a confident diagnosis of MS begin treatment ...

A diagnosis of multiple sclerosis (MS) can be life-changing and scary. MS is a chronic autoimmune disease affecting the central nervous system. Having this condition means the body’s immune system ...

Growing skin plaques with scale Increased incidence may be related to interferon beta exposure during treatment for multiple sclerosis. Patients with multiple sclerosis (MS) have a high rate of ...